# Josh Resnick

> Josh Resnick is a seed investor at RA Capital Management backing E-Commerce. See 16 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [RA Capital Management](https://shizune.co/investors/profile/ra-capital-management)
- Location: Los Angeles, United States
- Total investments: 16
- Last investment: Jun 2024
- Lead investor: 19%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/joshresnick1/

Josh Resnick is a seed investor at RA Capital Management in Los Angeles focused on E-Commerce and Biotechnology. Josh Resnick is the Co-Founder and General Partner of Pure Imagination Brands. He is a former Co-Founder and CEO of Sugarfina. He attended Wharton School of the University of Pennsylvania.

## Contacts

5 contacts available for Josh Resnick: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/josh-resnick?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $655k–$60M |
| Pre-Seed | $1.4M–$1.5M |
| Series A | $1M–$75M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| E-Commerce | 3 | 19% |
| Biotechnology | 3 | 19% |
| iOS | 2 | 13% |
| Mobile | 2 | 13% |
| Pharmaceutical | 2 | 13% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 25% |
| Series A | 4 | 25% |
| Pre-Seed | 3 | 19% |
| Series B | 2 | 13% |
| Series C | 1 | 6% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 10 | 63% |
| Switzerland | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bright Peak Therapeutics | Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties. | $90M | Series C | Jun 11, 2024 | https://brightpeaktx.com |
| Mariana Oncology | Mariana Oncology is a biotechnology research industry. | $175M | Series B | Sep 07, 2023 | https://www.marianaoncology.com |
| Upwage | Our mission is to create $1 trillion in new wealth for the 44% of Americans who make less than $16/hr, using the power of big data & AI. | $2M | Convertible Note | Apr 12, 2022 |  |
| Nguyen Coffee Supply | Nguyen Coffee Supply is an award-winning roaster and the first specialty Vietnamese coffee company in America importing and roasting in Brooklyn, New York. Founded in 2018 by 1st generation entrepreneur-activist Sahra Nguyen, the company's mission is to increase economic advancement for Vietnamese farmers through specialty coffee production,while building a diverse and inclusive coffee culture for all. We believe Vietnamese robusta is the future of specialty coffee and sustainable farming. | $2.6M | Seed | Mar 01, 2022 | https://nguyencoffeesupply.com/ |
| Mariana Oncology | Mariana Oncology is a biotechnology research industry. | $75M | Series A | Dec 01, 2021 | https://www.marianaoncology.com |
| Avilar Therapeutics | Avilar Therapeutics is a bio pharmaceutical company pioneering the discovery and development of extracellular protein degraders, a new frontier in targeted protein degradation | $60M | Seed | Nov 18, 2021 | https://www.avilar-tx.com/ |
| Bright Peak Therapeutics | Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. At Bright Peak, they are creating innovative cytokine therapeutics that are uniquely engineered to precisely control and expand desired biological properties. | $107M | Series B | Jun 10, 2021 | https://brightpeaktx.com |
| Uprising Food | Uprising foods are superfood keto chips and keto bread with 2 net carbs. | $1.3M | Series A | Jan 05, 2021 | https://www.uprisingfood.com/ |
| Quench Bio | Quench Bio is a developer of gasdermin biology drugs designed to treat severe inflammatory diseases.The company leverages insights into gasdermin biology and innate immunity to develop medicines with lead compounds that target and inhibit the pore-forming protein that mediates the release of inflammatory cytokines, alarmins, DNA and NETs, enablingpatients to get relief from inflammatory diseases. |  | Series A | Jan 27, 2020 | https://quenchbio.com |
| Comrad | Comrad is a wellness brand that creates comfortable, functional, and supportive socks for everything you do. | $1.5M | Pre-Seed | Mar 10, 2019 | https://www.comradsocks.com |

10 of 16 investments shown.

## Co-investors
- [Versant Ventures](https://shizune.co/investors/profile/versant-ventures) — VC Fund, 4 deals together
- [Pure Imagination Brands](https://shizune.co/investors/profile/pure-imagination-brands) — VC Fund, 3 deals together
- [Access Biotechnology](https://shizune.co/investors/profile/access-biotechnology) — VC Fund, 2 deals together
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund, 2 deals together
- [Anorak Ventures](https://shizune.co/investors/profile/anorak-ventures-2) — VC Fund, 2 deals together
- [Atlas Ventures](https://shizune.co/investors/profile/atlas-ventures) — VC Fund, 2 deals together

## About RA Capital Management

VC Fund · Boston, United States

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

5 contacts available at RA Capital Management.

| Name | Title | Profile |
| --- | --- | --- |
| Cristina Ghenoiu | Principal | https://shizune.co/investors/profile/cristina-ghenoiu |
| Ajay Yekkirala | VP, Head of Biology | https://shizune.co/investors/profile/ajay-yekkirala-9184 |
| Andrew Levin | Managing Director | https://shizune.co/investors/profile/andrew-levin |
| Barbara Herbst | Deputy Chief Compliance Officer | https://shizune.co/investors/profile/barbara-herbst |
| Dan Marks | Venture Senior Associate | https://shizune.co/investors/profile/dan-marks |

## Similar investors

### Similar industry
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund
- [Great Oaks Venture Capital](https://shizune.co/investors/profile/great-oaks-venture-capital) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Platforms Angel Investors in United States](https://shizune.co/investors/platforms-angel-investors-united-states)
- [Platforms Angel Investors](https://shizune.co/investors/platforms-angel-investors)

## FAQ

### What does Josh Resnick invest in?

Josh Resnick invests primarily in E-Commerce, Biotechnology and iOS startups, most often at Seed and Series A stage. Most of the 16 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Josh Resnick's check size?

Josh Resnick typically joins rounds of $655k–$60M at Seed, $1.4M–$1.5M at Pre-Seed and $1M–$75M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Josh Resnick participates in.

### How do I contact Josh Resnick?

Public channels for Josh Resnick include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Josh Resnick last invest?

The most recent investment recorded for Josh Resnick closed in Jun 2024. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co